ERBA to Launch LISA XL System in Europe and International Markets; Product to be Featured at MEDICA 2015

MIAMI, Nov. 15, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, will be introducing the new fully automated diagnostic testing instruments, the LISA XL ELISA Processor and Reader for Auto Immune and Infectious disease diagnostics, to the European and international markets at MEDICA 2015, the World Forum for Medicine, in Dusseldorf, Germany Nov. 16-19. The Company will also feature its entire product range, including, Chemistry Analyzers, Hematology analyzers, Urine Analyzers, Hb A1c Analysers and Coagulation systems.

The LISA XL, a fully automated 6 plate ELISA Processor and Reader, is a continuous loading system with 285 patient sample capacity, supported with the complete range of assays for Autoimmune and Infectious disease diagnostics.

About ERBA Diagnostics, Inc.

ERBA Diagnostics, Inc. (, headquartered in Miami, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distributes in the United States and internationally, proprietary diagnostic reagents, test kits and instrumentation, primarily for autoimmune and infectious diseases, through its three subsidiaries: Diamedix Corporation (U.S.), Delta Biologicals S.r.L. (Europe) and ImmunoVision, Inc. (U.S.).


MEDICA is the center of attraction for all those involved in the health care industry. Over 130,000 visitors from 120+ countries are expected to again obtain information on all the current and future trends in in-patient and out-patient care at this annual event. With its numerous special events, newly-restructured international conference and forum program, not to mention the largest and most comprehensive product display in the industry, MEDICA is the hub of the worldwide medical trade.

CONTACT: Mohan Gopalkrishnan 305 418 2320

Source:ERBA Diagnostics, Inc.